GSE183913
Transcriptomic profiling of MCF-7 breast cancer cells treated with Karanjin
Application of next generation sequencing (NGS) technology to identify karanjin-modulated genes in MCF-7 breast cancer cells Overall design: MCF-7 breast cancer cells treated with 10 µM karanjin (n=3) or vehicle (0.1% DMSO, n=3) for 24 h.